Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile.

Record checks

Study design

Randomized controlled trial

Subject

Human

Publication year

2024

Source

doi.org

Abstract display

Not reproduced here

Publication status

Active

Status checked

17 Aug 2026

Collected

3 Aug 2026

Freshness

Current

Review stage

Automated

Record status

Published

How to read this record →